Koninklijke Phil Stock Price, News & Analysis

Philips (NYSE: PHG) has announced a collaboration with March of Dimes to enhance maternal health education through the Philips Avent Pregnancy+ app. The partnership will integrate March of Dimes content into the app, focusing on critical topics such as NICU preparation, preterm birth, and vaccinations. The Pregnancy+ app, with over 80 million lifetime downloads, offers comprehensive pregnancy guidance including 800+ articles, 3D baby models, and expert-led courses.

The collaboration will emphasize the Low Dose, Big Benefits Campaign, promoting low dose aspirin for preventing pregnancy-related hypertensive disorders. Additionally, both organizations will conduct research using aggregated app data and surveys to gather insights for improving maternal and baby health outcomes.

Philips (NYSE: PHG) has launched the RADIQAL (Radiation Dose and Image Quality Trial) study to evaluate its new ultra-low X-ray dose technology for coronary procedures. The multicenter trial will enroll 824 patients across 6 hospitals in Spain, Czech Republic, Denmark, and the US, with the first patient enrolled at Aarhus University Hospital, Denmark.

The study aims to compare radiation exposure, image quality, and procedural performance between Philips' new ultra-low dose technology and existing ClarityIQ technology, both integrated into the Azurion image-guided therapy system. The new technology features an ultra-low dose protocol that reduces X-ray exposure by 50% compared to the lowest setting currently available on Azurion systems with ClarityIQ. The technology has received CE marking but is not yet FDA-cleared.

Philips (NYSE: PHG) has released its 10th annual Future Health Index (FHI) 2025 Report, revealing critical insights about AI's potential in healthcare and current system challenges. The report, spanning 16 countries, highlights that 33% of patients experienced deteriorating health due to doctor appointment delays, with some countries facing up to 4-month specialist wait times. Healthcare professionals lose approximately 23 full days annually due to data management issues, with 75% reporting lost clinical time from incomplete patient information.

While AI shows promise in transforming healthcare delivery, a significant trust gap exists - 34% more clinicians see AI's benefits compared to patients. Key concerns include liability for AI-driven errors (75% unclear about accountability), data bias risks, and the need for robust validation. The report suggests that by 2030, AI could potentially double patient capacity through administrative task automation and clinical assistance.

Philips (NYSE: PHG) has released its 2025 Future Health Index U.S. report revealing a significant trust gap in healthcare AI between healthcare professionals (HCPs) and patients. The report highlights that 63% of HCPs are optimistic about AI improving patient outcomes, while less than half of patients share this optimism, dropping to just 33% among patients aged 45 or over.

The study found that nearly 25% of HCPs would not choose healthcare as a career again due to stress and burnout. However, 85% of HCPs believe AI can reduce administrative burden, and 74% see AI improving patient access through increased capacity. 62% of healthcare professionals value AI's potential to enhance patient experience through shorter procedure times and reduced wait times, which currently average almost two months for specialist appointments.

Google Cloud and Philips (PHG) have announced a strategic collaboration to revolutionize Philips' digital asset management using AI technology. Leveraging Google Cloud's Vertex AI platform, Philips successfully processed and matched over 200,000 images into 8,000 unique, brand-aligned assets within hours. The solution utilizes a custom algorithm that recognizes visual structure and similarity across different image formats.

The collaboration has significantly enhanced Philips' marketing operations by streamlining asset governance, ensuring brand consistency, and reducing operational costs. The system can identify similar images even when cropped, resized, or reformatted, enabling faster touchpoint updates and reduced compliance risks. This innovation also enables new marketing opportunities, including accelerated A/B testing and improved campaign management support.